Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The oncogenic functions of SPARCL1 in bladder cancer

1 Nov 2024

Abstract excerpt

Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) belongs to the SPARC family of matricellular proteins. However, underlying functions of SPARCL1 in bladder cancer (BCa) remain understudied. We performed an integrated search for the expression patterns of SPARCL1 in relation to various clinicopathological features of BCa. We then carried out Gene Ontology (GO) enrichment analysis, Kyoto Encyclopedia...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39548034
DOI: 10.1111/jcmm.70196

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The oncogenic functions of SPARCL1 in bladder cancerPMID 39548034Read ↗

Associations of tumor suppressor SPARCL1 with cancer progression and prognosisSemantic proximity Read ↗

SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal CancerSemantic proximity Read ↗

Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironmentSemantic proximity Read ↗

Telomere maintenance-related genes are important for survival prediction and subtype identification in bladder cancerSemantic proximity Read ↗

Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder CancerSemantic proximity Read ↗

Identification of SPP1 as a Prognostic Biomarker and Immune Cells Modulator in Urothelial Bladder Cancer: A Bioinformatics AnalysisSemantic proximity Read ↗

PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltrationSemantic proximity Read ↗

Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancerSemantic proximity Read ↗

Upregulation of CHAC1 promotes bladder inflammation and predicts adverse prognosis in Bladder Urothelial CarcinomaSemantic proximity Read ↗

Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic modelSemantic proximity Read ↗

TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics studySemantic proximity Read ↗

Fibroblast Common Serum Response Signature-Related Classification Affects the Tumour Microenvironment and Predicts Prognosis in Bladder Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.